SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
林JJ的小可爱
Lv2
140 积分
2023-08-27 加入
最近求助
最近应助
互助留言
piRNAs and PIWI proteins as potential biomarkers in Breast cancer
1个月前
已完结
[Cancer incidence and mortality in China, 2022]
1个月前
已完结
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
1个月前
已完结
Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review
1个月前
已完结
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases
1个月前
已完结
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
1个月前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
1个月前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
1个月前
已完结
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2– metastatic breast cancer in the United States: A SEER‐Medicare population‐based study
1个月前
已完结
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases
1个月前
已完结
没有进行任何应助
输入错误【积分已退回】
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论